Latest News, Grants & Research Reports
Read our latest news, blog posts and research updates right here
Blood-tests for neuroblastoma clinical trials to guide next-generation cancer treatments.
In 2021, Neuroblastoma UK awarded £469,093 in research funding to an international team of leading clinician-scientists to explore how blood tests (biomarker testing) could be used in clinical trials to improve outcomes for children with neuroblastoma.
Rare Cancers Bill Passes Third Reading in House of Commons
The Rare Cancers Bill, led by Scott Arthur MP, has today passed its Third Reading in the House of Commons, bringing renewed hope to those affected by rare and less common cancers, including devastating childhood cancers such as neuroblastoma.
Act Now: The Rare Cancers Bill is at Risk
We need your help to ensure the Rare Cancers Bill passes its third reading.
After months of cross-party support and progress, the Rare Cancers Bill is now at serious risk of falling. We urgently need your help to make sure it passes.
Why We Run: Stories from Team Neuroblastoma UK
We've been truly inspired by our runners this year, especially with five incredible individuals representing Team Neuroblastoma UK in the TCS London Marathon.
As the 2025 marathon draws nearer, we caught up with two of our runners to hear about the daily routines that keep them motivated, the inspirations behind their journey, and ultimately - what drives them to run for our cause.
Charities come together for Teenage and Young Adult Cancer Awareness Month this April.
April is Teenage and Young Adult Cancer Awareness Month (TYACAM) – an opportunity for
charities and the young people we support to come together and raise awareness of the unique
set of challenges facing this age group after being told they have cancer.
BBC Lifeline Appeal
We are honored to announce that Neuroblastoma UK will be featured on the BBC Lifeline Appeal on Sunday, 26 January, at 13.50 on BBC One.
Neuroblastoma UK Awards £1.1 Million in 2024 Grant Round
Neuroblastoma UK is awarding £1.1 million in its 2024 grant round to fund new innovative research into neuroblastoma. New therapeutic approaches, pathways to improve existing treatments and exploration of an MRNA vaccine are just some of the projects to be funded in the 2024 grant round; with an emphasis on translational research which can be rapidly transferred from the lab bench to bedside.
North Nottinghamshire Prep School Releases Original Song to Support Neuroblastoma UK.
Pupils at Ranby House School in Retford, Nottinghamshire, have released an original song ‘Our Special Story’, in a bid to raise funds for Neuroblastoma UK.
New decision-making tool for treatment of relapsed and refractory neuroblastoma
We’re excited to share the launch of a brand-new tool for those navigating treatment pathways for high-risk neuroblastoma. The Redmapp Website is designed to support families facing the difficult decisions that come when their child is faced with uncertainty associated with more complex cases of neuroblastoma.
Research partly funded by Neuroblastoma UK leads to an innovative stem cell model providing insight into childhood cancer origins
Researchers from the University of Sheffield and St. Anna Children’s Cancer Research Institute have created a model designed to investigate the origins of neuroblastoma, a cancer primarily affecting infants and young children. The findings offer hope for the creation of tailored treatments which treat aggressive neuroblastomas and minimise the adverse effects experienced by patients from existing therapies.